CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

PR Newswire Pharma
Original article

Specialised Therapeutics Expands Partnership with Incyte to Include Ruxolitinib Cream (Opzelura®) in Australia

PartnershipOpzeluraPositive
AI Analysis

Summary

Specialised Therapeutics expanded its partnership with Incyte to commercialise, distribute, and register Opzelura (ruxolitinib cream) in Australia.

Importance:6/10
Sentiment:
0.60
partnership expansioncommercialisationgeographic expansionAustralia
Related Companies

Read the original article

Published by PR Newswire Pharma on September 20, 2026 8:00 PM

Read Original